PPD agrees acquisition of BioDuro

Posted on: Fri, 20 Nov 2009 10:32:00 EST


Symbols: PPDI
Nov 20, 2009 (M2 EQUITYBITES via COMTEX) --
PPDI | Quote | Chart | News | PowerRating -- Contract research organisation Pharmaceutical Product Development Inc
(PPD) (NASDAQ:PPDI) reported on Wednesday that it has entered into an
agreement to acquire drug discovery outsourcing company BioDuro LLC.

Financial details of the agreement were not disclosed.

This acquisition will expand PPD's drug development capabilities in
China, the company said.

BioDuro operates a 110,000-square-foot laboratory in Beijing and it
provides scientific expertise in medicinal chemistry, biology,
pharmacology, drug metabolism, pharmacokinetic and safety services.

The acquisition is expected to be completed in the fourth quarter of
2009.

Comments on this story may be sent to admin@m2.com

For full details on Pharmaceutical Prod Dev (PPDI) PPDI. Pharmaceutical Prod Dev (PPDI) has Short Term PowerRatings at TradingMarkets. Details on Pharmaceutical Prod Dev (PPDI) Short Term PowerRatings is available at This Link.

UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
Thursday February 11 04:30 PM
* Attendance is strictly limited and are filled on a first-come, first-served basis.